Asahi Kasei To Further Expand Kidney Dialyzers Market
This article was originally published in PharmAsia News
Executive SummaryRanked second worldwide in polysulfone dialysis products, Asahi Kasei Medical plans to further invest and expand the market for its core products APS dialyzers in 2009. With a strong yen, Asahi Kuraray Medical plans to establish overseas manufacturing bases and innovative product designs to lower production costs. With a dwindling domestic market, the company also looks to expand markets in Europe, the U.S. and emerging countries. It already started product assembly in China, and licensed technology to a Thailand factory. The company's German subsidiary Asahi Kasei Europe will distribute products to sales agents in each European country. (Click here for more - Japanese language
You may also be interested in...
An experienced hand at M&A, Ajay Piramal has done it again – this time selling Decision Resources Group to Clarivate Analytics for $950m. Apart from $900m in cash, Piramal Enterprises will get a stake in Clarivate while the latter expects the acquisition to be earnings-accretive in 2020.
San Francisco-based digital health start-up Steady Health has launched the first "virtual" full-service diabetes clinic for patients in California. See what Henrik Berggren, CEO and founder of Steady Health, said about it here.
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.